Within the framework of the NANOBIOTEC seminar series, Biochemist Hernán Ramírez, a member of the Bioinnovo team, presented his research titled “Design and evaluation of vaccine strategies for cattle against enterohemorrhagic Escherichia coli O157:H7, the causative agent of Hemolytic Uremic Syndrome in humans.” The…
INTA, the National Research Council of Canada (NRCC), and Bioinnovo—a technology-based company established jointly by INTA and Vetanco SA—are currently developing the first vaccine against the foot-and-mouth disease virus (FMDV) that completely eliminates the use of infective material in its manufacturing process. This achievement represents…
“We must take a three-pronged approach to address the problem: diagnosis, prevention through vaccination and biosecurity of facilities”. Said by Dr. Paul Walz, of the College of Veterinary Medicine at Auburn University, Alabama, in the United States, during the 3rd International Congress of Bovine Viral Diarrhea Virus (BVDV) organized…
At this year’s event, which will be held under the theme “Impact and Management of BVD Virus in Cattle,” international experts will discuss strategies to control this disease and mitigate its impact on livestock. Next August 28 at 6:00 PM, the 3rd International Congress on Bovine Viral Diarrhea…
The world’s first targeted vaccine against the Bovine Viral Diarrhea Virus (BVDV), developed by Bioinnovo, was one of 4 finalists in its category among around 1,000 projects submitted at the 13th edition of the Pioneering Solutions Contest from Banco Nación, aimed at SMEs and enterprises….
Knowledge about the impact of this virus on production and control measures to mitigate its effect on the herd was disseminated at the Second International Congress on Bovine Viral Diarrhea Virus (BVDV), convened by Bioinnovo and INTA. The Second International BVDV Congress, held virtually by…
Bioinnovo has participated in 2021 ISV Annual Virtual Congress by sharing experiences in the development of innovative veterinary vaccines to fight against several diseases, and by introducing the successful case of Vedevax Block, the first subunit recombinant vaccine in the world that has been approved…
The Workshop “BVDV Differential Diagnosis and Management Strategies” took place as part of the first International Congress on BVDV. Bioinnovo, the first public-private company created by Vetanco and the National Institute of Agricultural Technology (INTA), aimed at investigating, designing and developing IgY antibodies and recombinant vaccines, and at…
The second day of the First International Congress on Bovine Viral Diarrhea Virus (BVDV) was held last Monday, August 2, and dealt with the different available vaccines and vaccination strategies to fight against this virus, responsible for millions of dollars in losses to national farms….
On Monday, July 12, and August 2, 2021, Bioinnovo organizes the First International Congress of Bovine Viral Diarrhea Virus (BVDV), which will be held virtually. Bioinnovo, a public-private partnership between Vetanco and INTA, is the organizer of the First International Congress of Bovine Viral Diarrhea Virus, to be…